Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Pharmacol Res ; 153: 104637, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-31935454

RESUMO

The Aidi injection contains multiple active ingredients, including astragaloside (Re, Rb1, and Rg1), ginsenoside, cantharidin, elentheroside E, and syringin, and it is administered with vinorelbine and cisplatin (NP) to treat non-small-cell lung carcinoma (NSCLC). In this study, we performed a systematic review and meta-analysis to determine the clinical efficacy and safety of the Aidi injection with NP, and the optimal threshold and treatment regimen to produce the desired responses. We collected all studies regarding the Aidi injection with NP for NSCLC from Chinese and English databases (up to April 2019). Risk of methodological bias was evaluated for each study. Data for analysis were extracted using a standard data extraction form. Evidence quality was assessed following the Grading of Recommendations Assessment, Development and Evaluation approach. We included 54 trials containing 4,053 patients for analysis. Combining the Aidi injection with NP significantly increased the objective response rate (odds ratio [OR], 1.32; confidence interval [CI], 1.23, 1.42), disease control rate (OR, 1.14; CI, 1.11, 1.18), and quality of life (OR, 1.80; CI, 1.61, 1.98), with decreased risks of myelosuppression, neutropenia, thrombocytopenia, anemia, gastrointestinal reaction, and liver dysfunction. For patients with a Karnofsky Performance Status score of ≥60, the Aidi injection (50 mL/day, two weeks/cycle, with two to three cycles) treatment with vinorelbine (25 mg/m2) and cisplatin (30-35 mg/m2 or 40-50 mg/m2) might be the optimal regimen for producing the desired tumor response and achieving a good safety level. Most results were robust, and their quality was moderate. The results suggest that administration of the Aidi injection and concomitant NP is beneficial to NSCLC, and provide evidence for the optimal threshold and treatment regimen that may improve tumor response with a good safety level.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico , Cisplatino/uso terapêutico , Medicamentos de Ervas Chinesas/uso terapêutico , Neoplasias Pulmonares/tratamento farmacológico , Vinorelbina/uso terapêutico , Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Cisplatino/administração & dosagem , Cisplatino/efeitos adversos , Medicamentos de Ervas Chinesas/administração & dosagem , Medicamentos de Ervas Chinesas/efeitos adversos , Humanos , Injeções , Qualidade de Vida , Ensaios Clínicos Controlados Aleatórios como Assunto , Resultado do Tratamento , Vinorelbina/administração & dosagem , Vinorelbina/efeitos adversos
2.
Sichuan Da Xue Xue Bao Yi Xue Ban ; 51(4): 552-555, 2020 Jul.
Artigo em Zh | MEDLINE | ID: mdl-32691566

RESUMO

OBJECTIVE: To analyze the pathological characteristics and explore the optimal surgical margins (SM) of nephron-sparing surgery (NSS) for stage T 1b renal carcinoma (4-7 cm) on preoperative imaging. METHODS: The clinical and pathological data of 245 cases of stage T 1b kidney cancer from September 2013 to December 2017 were collected and reviewed retrospectively. The radical nephrectomy (RN) was performed on 174 cases and other 71 cases accepted NSS. There were 158 males and 87 females, with a mean age of 59.6 years and mean tumor size of 5.3 cm. RESULTS: Through postoperative pathological examination, 209 (85.3%) cases were confirmed renal clear cell carcinoma and 219 (89.4%) cases were surrounded with visible peritumoralpseudocapsule (PC). 26 (10.6%) cases of cancerous cells invaded beyond peritumoral PC and into renal parenchyma. The infiltrative depth into renal parenchyma beyond PC was all limited in 3 mm and the cases of ≤1, 1-2 and 2-3 mm were 7 (26.9%), 16 (61.5%) and 3 (11.5%), respectively. Multifocal tumors were discovered in 24 (9.8%) cases. The average resection margin for partial nephrectomy was 5 mm (3-7 mm). CONCLUSION: For stage T 1b renal tumors, NSS is acceptable and a 3 mm of surgical margin is safe and suitable to avoid positive SM.


Assuntos
Carcinoma de Células Renais , Neoplasias Renais , Margens de Excisão , Nefrectomia , Carcinoma de Células Renais/cirurgia , Feminino , Humanos , Neoplasias Renais/cirurgia , Masculino , Pessoa de Meia-Idade , Nefrectomia/métodos , Néfrons/cirurgia , Estudos Retrospectivos
3.
Tumour Biol ; 35(3): 2095-102, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24092576

RESUMO

Pioglitazone is widely used for glycemic control in patients with type 2 diabetes mellitus, but evidence regarding the association between pioglitazone and bladder cancer risk is confusing. A systematic search of databases was carried out, and other relevant papers were also identified. Then, the analyses were conducted according to the PRISMA and MOOSE guidelines. After quality assessment, nine datasets from 10 available studies were included on the basis of inclusion criteria. The incidence of bladder cancer among pioglitazone ever users and never users, pooled from four cohort and one randomized studies, were 84.51 and 66.68 per 100,000 person-years, respectively. Nine studies representing 2,596,856 diabetic patients were recognized as eligible for overall study; the result suggested an increased risk of bladder cancer in patients exposed to pioglitazone. A persistent significance was detected after being adjusted by age, gender, and use of other diabetes medications. Subgroup analyses indicated that the significantly increased incidence of bladder cancer was found in men, but not in women. Additionally, the analyses addressing increasing exposure to pioglitazone observed a dose-response relation between exclusive ever use of pioglitazone and bladder cancer in terms of cumulative duration of use and cumulative dosage. With some limitations, our results suggest an increased risk of bladder cancer in diabetic patients using pioglitazone, especially for men with long-term and high-dose exposure. Additional studies are needed to provide more precise evidences to support our results.


Assuntos
Diabetes Mellitus Tipo 2/tratamento farmacológico , Hipoglicemiantes/efeitos adversos , Tiazolidinedionas/efeitos adversos , Neoplasias da Bexiga Urinária/induzido quimicamente , Neoplasias da Bexiga Urinária/epidemiologia , Feminino , Humanos , Incidência , Masculino , Pioglitazona , Fatores de Risco
4.
J Hazard Mater ; 472: 134469, 2024 Jul 05.
Artigo em Inglês | MEDLINE | ID: mdl-38691995

RESUMO

The scarcity of selective adsorbents for efficient extraction and removal of microcystins (MCs) from complex samples greatly limits the precise detection and effective control of MCs. Three-dimensional covalent organic frameworks (3D COFs), characterized by their large specific surface areas and highly ordered rigid structure, are promising candidates, but suffer from lack of specific recognition. Herein, we design to engineer molecularly imprinted cavities within 3D COFs via molecularly imprinted technology, creating a novel adsorbent with exceptional selectivity, kinetics and capacity for the efficient extraction and removal of MCs. As proof-of-concept, a new CC bond-containing 3D COF, designated JNU-7, is designed and prepared for copolymerization with methacrylic acid, the pseudo template L-arginine and ethylene dimethacrylate to yield the JNU-7 based molecularly imprinted polymer (JNU-7-MIP). The JNU-7-MIP exhibits a great adsorption capacity (156 mg g-1) for L-arginine. Subsequently, the JNU-7-MIP based solid-phase extraction coupled with high performance liquid chromatography-mass spectrometry achieves low detection limit of 0.008 ng mL-1, wide linear range of 0.025-100 ng mL-1, high enrichment factor of 186, rapid extraction of 10 min, and good recoveries of 92.4%-106.5% for MC-LR. Moreover, the JNU-7-MIP can rapidly remove the MC-LR from 1 mg L-1 to levels (0.26-0.35 µg L-1) lower than the WHO recommended limit for drinking water (1 µg L-1). This work reveals the considerable potential of 3D COF based MIPs as promising adsorbents for the extraction and removal of contaminants in complex real samples.


Assuntos
Microcistinas , Impressão Molecular , Extração em Fase Sólida , Poluentes Químicos da Água , Microcistinas/isolamento & purificação , Microcistinas/química , Microcistinas/análise , Adsorção , Extração em Fase Sólida/métodos , Poluentes Químicos da Água/química , Poluentes Químicos da Água/isolamento & purificação , Poluentes Químicos da Água/análise , Estruturas Metalorgânicas/química , Arginina/química , Polímeros Molecularmente Impressos/química , Cromatografia Líquida de Alta Pressão , Limite de Detecção
5.
Front Immunol ; 13: 997265, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36263042

RESUMO

The membrane-associated RING-CH (MARCH) family, a member of the E3 ubiquitin ligases, has been confirmed by a growing number of studies to be associated with immune function and has been highlighted as a potential immunotherapy target. In our research, hepatocellular carcinoma (HCC) patients were divided into C1 and C2 MARCH ligase-related patterns by the non-negative matrix factorization (NMF) algorithm. Multiple analyses revealed that the MARCH ligase-related cluster was related to prognosis, clinicopathological characteristics, and the tumor immune microenvironment (TIME). Next, the signature (risk score) of the MARCH prognosis was constructed, including eight genes associated with the MARCH ligase (CYP2C9, G6PD, SLC1A5, SPP1, ANXA10, CDC20, PON1, and FTCD). The risk score showed accuracy and stability. We found that the correlations between risk score and TIME, tumor mutation burden (TMB), prognosis, and clinicopathological characteristics were significant. Additionally, the risk score also had important guiding significance for HCC treatment, including chemotherapy, immunotherapy, and transarterial chemoembolization (TACE).


Assuntos
Carcinoma Hepatocelular , Quimioembolização Terapêutica , Neoplasias Hepáticas , Humanos , Carcinoma Hepatocelular/terapia , Carcinoma Hepatocelular/tratamento farmacológico , Neoplasias Hepáticas/genética , Citocromo P-450 CYP2C9 , Ubiquitina-Proteína Ligases/metabolismo , Ubiquitinas , Microambiente Tumoral , Antígenos de Histocompatibilidade Menor , Sistema ASC de Transporte de Aminoácidos , Arildialquilfosfatase
6.
Front Med (Lausanne) ; 8: 651556, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34211983

RESUMO

Objectives: Both coronavirus disease 2019 (COVID-19) pneumonia and influenza A (H1N1) pneumonia are highly contagious diseases. We aimed to characterize initial computed tomography (CT) and clinical features and to develop a model for differentiating COVID-19 pneumonia from H1N1 pneumonia. Methods: In total, we enrolled 291 patients with COVID-19 pneumonia from January 20 to February 13, 2020, and 97 patients with H1N1 pneumonia from May 24, 2009, to January 29, 2010 from two hospitals. Patients were randomly grouped into a primary cohort and a validation cohort using a seven-to-three ratio, and their clinicoradiologic data on admission were compared. The clinicoradiologic features were optimized by the least absolute shrinkage and selection operator (LASSO) logistic regression analysis to generate a model for differential diagnosis. Receiver operating characteristic (ROC) curves were plotted for assessing the performance of the model in the primary and validation cohorts. Results: The COVID-19 pneumonia mainly presented a peripheral distribution pattern (262/291, 90.0%); in contrast, H1N1 pneumonia most commonly presented a peribronchovascular distribution pattern (52/97, 53.6%). In LASSO logistic regression, peripheral distribution patterns, older age, low-grade fever, and slightly elevated aspartate aminotransferase (AST) were associated with COVID-19 pneumonia, whereas, a peribronchovascular distribution pattern, centrilobular nodule or tree-in-bud sign, consolidation, bronchial wall thickening or bronchiectasis, younger age, hyperpyrexia, and a higher level of AST were associated with H1N1 pneumonia. For the primary and validation cohorts, the LASSO model containing above eight clinicoradiologic features yielded an area under curve (AUC) of 0.963 and 0.943, with sensitivity of 89.7 and 86.2%, specificity of 89.7 and 89.7%, and accuracy of 89.7 and 87.1%, respectively. Conclusions: Combination of distribution pattern and category of pulmonary opacity on chest CT with clinical features facilitates the differentiation of COVID-19 pneumonia from H1N1 pneumonia.

7.
Phytomedicine ; 76: 153260, 2020 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-32535483

RESUMO

BACKGROUND: Aderivative of Shiitake mushrooms, Lentinan is used to control malignant pleural effusion (MPE) through intrathoracic infusion. PURPOSE: To determine the clinical response, survival and safety of Lentinan plus chemical irritants, and the optimal combinations with chemical irritants, indication, threshold and optimal regimen for achieving the desired responses. STUDY DESIGN: We performed a new systematic review and meta-analysis following the PRISMA guidelines. METHODS: We collected all randomized controlled trials (RCTs) regarding Lentinan plus chemical irritants from Chinese and English electronic databases (from inception until March 2019). We evaluated their bias risk, synthesized data using meta-analysis, and summarized evidence quality following the Grades of Recommendation Assessment, Development and Evaluation approach. RESULTS: We included 65 RCTs involving 4,080 patients and nine chemical irritants. Most trials had unclear bias risk. Lentinan with cisplatin significantly improved complete response [Risk ratio (RR) = 1.68, 95% confidence intervals (CI) (1.51 to 1.87), p < 0.00001, Fig.3a] and quality of life [RR = 1.51 95% CI (1.41 to 1.62), p < 0.00001, Fig.4], and decreased the risk of treatment failure, myelosuppression, gastrointestinal reaction, and chest pain. For patients with moderate to large volume of the pleural effusion, primary treatment, KPS score ≥ 50-60, or anticipated survival time ≥ 3months, Lentinan (3-4 mg/time, once a week for three to four times) withcisplatin (30-40 mg/m2 or 50-60 mg/m2) significantly improved complete response and decreased failure. Most results were robust and moderate quality. CONCLUSION: The results suggest that Lentinan with chemical irritants, especially cisplatin is beneficial to the patient with MPE, and provide evidence for the indication, threshold, and optimal regimen that may achieve success and decrease failure.

8.
Clin Ther ; 42(3): 515-543.e31, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-32088021

RESUMO

PURPOSE: Chemotherapy-induced hepatorenal toxicity often decreases tolerance for further therapies and results in poor quality of life and prognosis for patients with lung cancer. In this meta-analysis, all related studies were systematically re-evaluated to determine whether Aidi injection relieves hepatorenal toxicity and improves tumor response, and to determine its threshold and the optimal treatment regimen for obtaining the desired responses. METHODS: All studies regarding Aidi injection with chemotherapy were gathered from Chinese and English databases (from inception until January 2019). Their bias risk was evaluated and the data were synthesized using meta-analysis; the quality of evidence of all outcomes was rated by using the Grades of Recommendation Assessment, Development, and Evaluation approach. FINDINGS: Eighty randomized controlled trials containing 6279 patients were included in the study. Most of the trials showed unclear risk of bias. Aidi injection with chemotherapy increased the objective response rate (risk ratio [RR], 1.32; 95% CI, 1.25-1.40) and the disease control rate (RR, 1.15; 95% CI, 1.12-1.17) and resulted in a lower incidence of hepatotoxicity (RR, 0.61; 95% CI, 0.55-0.69) and nephrotoxicity (RR, 0.62; 95% CI, 0.53-0.72) than that of chemotherapy alone. Subgroup analyses showed that treatment with 50 mL per time, 10 to 14 days per cycle, and 2 to 3 cycles of Aidi injection with chemotherapy resulted in a low incidence of hepatorenal toxicity. All of the results were robust, and their quality was moderate. IMPLICATIONS: The moderate evidence indicates that Aidi injection with chemotherapy may improve tumor response and result in a low incidence of hepatorenal toxicity in patients with lung cancer. Aidi injection may relieve hepatorenal toxicity and exhibit an important protective effect against chemotherapy-induced hepatorenal toxicity. Based on the subgroup analysis results, Aidi injection seems to lower the threshold for chemotherapy. Treatment with 50 mL per time, 10 to 14 days per cycle, and 2 to 3 cycles may be the optimal usage for attaining a decrease in hepatorenal toxicity.


Assuntos
Injúria Renal Aguda , Antineoplásicos , Doença Hepática Induzida por Substâncias e Drogas/tratamento farmacológico , Medicamentos de Ervas Chinesas , Neoplasias Pulmonares/tratamento farmacológico , Injúria Renal Aguda/induzido quimicamente , Injúria Renal Aguda/tratamento farmacológico , Antineoplásicos/efeitos adversos , Antineoplásicos/uso terapêutico , Medicamentos de Ervas Chinesas/administração & dosagem , Medicamentos de Ervas Chinesas/uso terapêutico , Humanos , Injeções , Ensaios Clínicos Controlados Aleatórios como Assunto
9.
Sheng Li Xue Bao ; 61(1): 43-8, 2009 Feb 25.
Artigo em Zh | MEDLINE | ID: mdl-19224053

RESUMO

The experiments were carried out to test whether acid-sensing ion channel 1a and 3 (ASIC1a and ASIC3) were expressed on the primarily cultured type I cells of rat carotid bodies (CBs) and whether the expression of the channels was affected by acid stimulation. The Sprague-Dawley rats of either sex (50-100 g) were used. The CBs were isolated and primarily cultured. The immunofluorescent technique was used to detect the expression of tyrosine hydroxylase (TH), a specific marker of type I cells, in order to identify the type of the cultured cells. The double-label immunofluorescent technique was used to detect the expression of ASIC1a and ASIC3 on the TH-positive type I cells. To detect the influence of acid stimulation on the expressions of ASIC1a and ASIC3, each batch of primarily cultured cells were randomly divided into pH7.3 group (control group), pH6.8 group and pH6.2 group (n=9 in each group). The cells in above three groups were treated with pH7.3, pH6.8 and pH6.2 mediums for 24 h, respectively, and then the mRNA expressions of ASIC1a and ASIC3 in type I cells were detected by semi-quantitative RT-PCR technique. The results showed that more than 93% of the primarily cultured CB cells were TH-positive, indicating that most of the cultured cells were type I cells. Furthermore, all TH-positive cells expressed ASIC1a or ASIC3. After the cells were treated with acid stimulation, the amount of ASIC1a mRNA did not change significantly (P>0.05 vs control group); the amount of ASIC3 mRNA had no significant change in pH6.8 group compared with that in control group, but decreased significantly in pH6.2 group (P<0.01 vs control group, P<0.05 vs pH6.8 group). It is concluded that acid stimulation down-regulates the level of ASIC3 mRNA, but has no effect on the level of ASIC1a mRNA.


Assuntos
Canais Iônicos Sensíveis a Ácido/metabolismo , Corpo Carotídeo/citologia , Ácidos/farmacologia , Animais , Corpo Carotídeo/metabolismo , Células Cultivadas , Feminino , Masculino , Ratos , Ratos Sprague-Dawley
10.
Sichuan Da Xue Xue Bao Yi Xue Ban ; 40(4): 662-6, 2009 Jul.
Artigo em Zh | MEDLINE | ID: mdl-19764568

RESUMO

OBJECTIVE: To investigate the expression of three acid-sensing ion channel (ASIC) subtypes termed as ASIC1b, ASIC2a, and ASIC3 in the neurons of trapezoid body and lateral paragigantocellular nucleus of rat brainstem, and the effects of intermittent hypoxia on their expression. METHODS: The intermittent hypoxic rat model was established, of which the blood gas analysis was tested after 12 days. The immunohistochemistry SABC method was performed to test the expression of ASIC1b, ASIC2a, and ASIC3 in neurons of trapezoid body and lateral paragigantocellular nucleus in the control (O2) and intermittent hypoxic (IH) groups of rats. RESULTS: The ASIC1b-, ASIC2a- and ASIC3-positive immunoreactive neurons all could be observed in the nucleus of trapezoid body and lateral paragigantocellular nucleus. The intermittent hypoxia group, the numerical density of ASIC1b-positive immunoreactive neurons (cell/mm3) decreased in the nucleus of trapezoid body (P<0.05), but did not significantly change in the lateral paragigantocellular nucleus (P>0.05), the grey level did not significantly change in both the nucleus of trapezoid body and lateral paragigantocellular nucleus (P>0.05); the numerical density of ASIC2a-positive immunoreactive neurons (cell/mm3) did not significantly change in the nucleus of trapezoid body and lateral paragigantocellular nucleus (P>0.05), the grey level in the nucleus of trapezoid body increased (P<0.05) while it did not significantly change in the lateral paragigantocellular nucleus (P>0.05); the numerical density of ASIC3-positive immunoreactive neurons (cell/mm3) decreased in the lateral paragigantocellular nucleus (P<0.05), but it did not significantly change in the nucleus of trapezoid body (P>0.05), the grey level did not significantly change in the nucleus of trapezoid body and lateral paragigantocellular nucleus (P>0.05). CONCLUSION: The ASIC1b, ASIC2a, and ASIC3 exist in the neurons of trapezoid body and lateral paragigantocellular nucleus in the rat brainstem under normal condition, and their expressions in the two nuclei are different to intermittent hypoxia, which means that the roles of subtype of ASICs in different area may be different in the respiratory effects induced by hypoxia.


Assuntos
Tronco Encefálico/metabolismo , Hipóxia/metabolismo , Proteínas do Tecido Nervoso/metabolismo , Neurônios/metabolismo , Canais de Sódio/metabolismo , Canais Iônicos Sensíveis a Ácido , Animais , Feminino , Masculino , Distribuição Aleatória , Ratos , Ratos Sprague-Dawley , Respiração
11.
Shanghai Kou Qiang Yi Xue ; 28(6): 581-585, 2019 Dec.
Artigo em Zh | MEDLINE | ID: mdl-32346699

RESUMO

PURPOSE: This study was aimed to compare the incidence of dentinal microcracks produced by 3 kinds of Ni-Ti instruments during root canal procedures in severely curved canals. METHODS: Two hundred and forty extracted human molars with mesial roots of 25° to 40° curvatures were selected and divided into A, B, C group, with 80 teeth in each group according to root curvature of 25°-30°ï¼ˆexcluding 25°ï¼‰, 30°-35°,35°-40°. Each of them was prepared with K file to 15#. Then, each group was divided into 4 sub-groups (n=20), one was as control, the others were prepared with WaveOne, ProTaper Next and M3-Pro, respectively. After preparation, all roots were stained with 1% methylene blue for 24 hours. The roots were then sectioned at the most curved plane and 2mm below and above the most curved plane with alow-speed saw under cold water. Stereomicroscope was used to inspect dentinal microcracks and differences between each group were analyzed using Chi-square test with SPSS 20.0 software package. RESULTS: Microcracks were observed in the group of WaveOne, ProTaper Next and M3-Pro. WaveOne system induced more dentinal microcracks compared with ProTaper Next and M3-Pro system (P<0.05), and there was no significant difference between ProTaper Next and M3-Pro system (P>0.05). The number of dentinal microcracks in WaveOne, ProTaper Next and M3-Pro group increased with the increase of root curvature. Except Waveone in group A (25°-30°) and group C (35°-40°), the occurrence of dentinal microcracks in two groups had significant difference (P<0.05), there was no significant difference among other groups (P>0.05). CONCLUSIONS: Compared to WaveOne, ProTaper Next and M3-Pro are more suitable for severely curved canal preparation.


Assuntos
Cavidade Pulpar , Preparo de Canal Radicular , Humanos , Níquel , Titânio
12.
Int Immunopharmacol ; 75: 105747, 2019 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-31326719

RESUMO

BACKGROUND: Synthetic thymic peptides (sTPs) are used with chemotherapy to treat non-small cell lung cancer (NSCLC). In this study, we have performed a systematic review and meta-analysis of published trials to confirm the clinical efficacy and safety of sTPs, and determine the optimal types, usages, and sTP/chemotherapy combinations to produce the desired responses. MATERIALS AND METHODS: We collected all studies regarding combined sTP therapy and chemotherapy for NSCLC from the Chinese and English databases (up to October 2018). Bias risk was evaluated for each. Data for meta-analysis was extracted using a pre-designed form. Evidence quality was rated using the Grading of Recommendations Assessment, Development and Evaluation approach. RESULTS: We included 27 randomized controlled trials containing 1925 patients, most with unclear bias risk. Combining sTPs with chemotherapy significantly increased the objective response rate [1.28, (1.13 to 1.45)], disease control rate [1.10, (1.01 to 1.18)], quality of life (QOL) [2.05, (1.62, 2.60)], and 1-year overall survival rate [1.43, (1.15 to 1.78)], with decreased risks of neutropenia, thrombocytopenia, and gastrointestinal reactions. Optimal conditions included treatment in combination with gemcitabine or navelbine and cisplatin, twice a week, with one 3-week cycle. In these conditions, thymosin α1 improved both antitumor immunity and tumor response. Most results had good robustness, and their quality ranged from moderate to very low. CONCLUSIONS: The results suggest that treatment with sTPs, especially thymosin α1, and concomitant chemotherapy is beneficial to the patient, and provide evidence for optimal treatment regimens that may increase patient QOL and survival.


Assuntos
Antineoplásicos/administração & dosagem , Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico , Neoplasias Pulmonares/tratamento farmacológico , Peptídeos/administração & dosagem , Hormônios do Timo/administração & dosagem , Antineoplásicos/efeitos adversos , Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , China , Humanos , Peptídeos/efeitos adversos , Ensaios Clínicos Controlados Aleatórios como Assunto , Hormônios do Timo/efeitos adversos , Resultado do Tratamento
13.
Brain Res ; 1092(1): 207-13, 2006 May 30.
Artigo em Inglês | MEDLINE | ID: mdl-16674929

RESUMO

Coriaria Lactone (CL) is a mixture that has been used to establish animal models of epilepsy. In this study, we focused on the epileptogenic action of tutin, a pure chemical component derived from CL. Rats were implanted with a guide cannula for microinjection of tutin into either of the lateral cerebral ventricles. Behavioral and electroencephalographic (EEG) changes were investigated for at least 2 h after tutin administration. Injected animals presented behavioral seizures: initially, facial and limbic clonus, and subsequently, tonic-clonic seizures that eventually progressed to status epilepticus. Accompanying the behavioral activities, a variety of EEG patterns were recorded. Spike-and-wave complexes occurred continuously at 3 Hz, with a mean amplitude of approximately 295 microV. Multiple spikes and slow waves occurred repetitively and became more frequent and intense. The amplitude of this EEG pattern was low (approximately 85 microV) at onset and gradually increased to approximately 200 microV. Spikes (8 Hz, approximately 555 microV) and slow waves (3 Hz, approximately 670 microV) occurred periodically at the onset of grand mal seizures. Behavioral and EEG changes induced in rats by tutin demonstrated that this is a potent convulsant, by which a new animal model of status epilepticus was established. This acute seizure model is productive and would be optional for investigation of seizures or status epilepticus.


Assuntos
Encéfalo/efeitos dos fármacos , Encéfalo/fisiopatologia , Convulsivantes/farmacologia , Epilepsia/induzido quimicamente , Epilepsia/fisiopatologia , Sesquiterpenos/farmacologia , Potenciais de Ação/efeitos dos fármacos , Potenciais de Ação/fisiologia , Doença Aguda , Animais , Modelos Animais de Doenças , Eletroencefalografia/efeitos dos fármacos , Epilepsia/diagnóstico , Epilepsia Tônico-Clônica/induzido quimicamente , Epilepsia Tônico-Clônica/diagnóstico , Epilepsia Tônico-Clônica/fisiopatologia , Feminino , Injeções Intraventriculares , Masculino , Picrotoxina/análogos & derivados , Valor Preditivo dos Testes , Ratos , Ratos Sprague-Dawley , Estado Epiléptico/induzido quimicamente , Estado Epiléptico/diagnóstico , Estado Epiléptico/fisiopatologia
15.
Sheng Li Xue Bao ; 56(3): 341-6, 2004 Jun 25.
Artigo em Zh | MEDLINE | ID: mdl-15224147

RESUMO

Previous studies showed that a mixture, Coriaria Lactone (CL), extracted from a traditional Chinese herb Loranthus Parasiticus Mer, had a great excitatory influence on the nervous system, resulting in seizure. But what component in CL causes seizure is unclear. Tutin is a pure chemical component derived from CL. The present experiments were carried out to test if tutin has any epileptogenic action and to preliminarily study the mechanism underlying that action in vitro. The electrical activity of CA1 pyramidal cells, population spikes (PS), evoked by stimulation of the Schaffer collaterals in rat hippocampal slices was recorded extracellularly. The effects of tutin on the PS and the antagonistic actions of CNQX and AP-5 on the tutin-induced effects were investigated. The results are as follows. (1) Superfusion with 40, 30 and 20 microg/ml tutin caused significant increase in the amplitude and number of PS waves evoked by stimulating the Schaffer collaterals. Thirty minutes after superfusion of tutin, the amplitude of the first wave of the PSs was increased by (388.7+/-0.1)%, (317.2+/-19.1)% and (180.9+/-11.6)% in each of the above three groups, respectively, compared with the control (for each group, n=5, P<0.05). (2) With increase in amplitude, the PS number was increased to 4~11 waves from a single wave in the control and manifested multiple epileptiform discharges 30 min superfusion with tutin. (3) Spontaneous epileptiform discharges of CA1 pyramidal cells were obtained in 9 out of 34 cases after tutin superfusion. (4) The tutin-induced multiple epileptiform discharges of the CA1 pyramidal cells were completely blocked by CNQX, in aspects of both amplitude and number of the PS. Following the application of AP-5, the increase in the wave number of the tutin-induced epileptiform discharges was inhibited but the increase in the amplitude of the discharges was not significantly affected. These results indicate that tutin can induce typical multiple epileptiform discharges of CA1 pyramidal cells in rat hippocampal slices and might be used as an efficient epileptogenic agent, and that the excitable glutamate receptors, especially the non-NMDA receptors, may participate in the genesis of tutin-induced epileptiform discharges.


Assuntos
Epilepsia/induzido quimicamente , Hipocampo/fisiopatologia , Células Piramidais/fisiopatologia , Sesquiterpenos/farmacologia , Animais , Eletrofisiologia , Epilepsia/fisiopatologia , Feminino , Masculino , Picrotoxina/análogos & derivados , Ratos , Ratos Sprague-Dawley
16.
Zhonghua Xue Ye Xue Za Zhi ; 33(1): 43-6, 2012 Jan.
Artigo em Zh | MEDLINE | ID: mdl-22575192

RESUMO

OBJECTIVE: To explore the effects and the molecular mechanism of puerariae radix flavones (PRF) on acute myeloid leukemia cell line Kasumi-1 cells in vitro. METHODS: Kasumi-1 cells treated by PRF for 48 hours were observed with Wright's and Hoechst 33258 dying. The apoptotic cells were analyzed by flow cytometry with AnnexinV/PI staining. The expression levels of bcl-2, Bim and Caspase-3/-8/-9 protein were assayed by Western blot and the AML1-ETO fusion gene was detected by real-time polymerase chain reaction. RESULTS: PRF could induce Kasumi-1 cells to apoptosis effectively. The proportion of apoptotic cells in 50, 200 and 500 µg/ml PRF treatment groups were (14.1 ± 0.8)%, (17.7 ± 1.3)% and (32.4 ± 1.4)%, respectively, and significantly higher than that of control \[(7.8 ± 0.7)%\]. The relative expression levels of the anti-apoptotic Bcl-2 protein were 0.85 ± 0.05, 0.62 ± 0.07 and 0.43 ± 0.05; the apoptotic Bim protein were 0.21 ± 0.06, 0.39 ± 0.04 and 0.75 ± 0.05; the caspase-3 and caspase-9 were 0.92 ± 0.04, 1.21 ± 0.07, 1.33 ± 0.04 and 0.35 ± 0.05, 0.53 ± 0.03, 0.69 ± 0.07, respectively. Compared to the blank control group, all these changes were significant (P < 0.01). Nevertheless, nearly no changes could be observed on the expression level of AML1-ETO fusion gene and caspase-8 protein. CONCLUSION: Apoptosis of Kasumi-1 cells induced by PRF might correlate to the down-regulation of Bcl-2 protein expression and the activation of caspase-3 and caspase-8 protein in the cells. It seemed that all these effects had no relationship with the AML1-ETO fusion gene.


Assuntos
Apoptose/efeitos dos fármacos , Flavonas/farmacologia , Pueraria , Caspase 3/metabolismo , Caspase 8/metabolismo , Linhagem Celular Tumoral , Subunidade alfa 2 de Fator de Ligação ao Core/genética , Subunidade alfa 2 de Fator de Ligação ao Core/metabolismo , Humanos , Proteínas de Fusão Oncogênica/genética , Proteínas de Fusão Oncogênica/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Proteína 1 Parceira de Translocação de RUNX1
17.
Respir Physiol Neurobiol ; 178(2): 230-4, 2011 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-21723961

RESUMO

We previously reported that exogenous H(2)S played roles in protection of respiratory centers against hypoxic injury in medullary slices of neonatal rats. The protective action of endogenous H(2)S and its relation to antioxidation and down-regulation of c-fos mRNA were investigated in the present study. Perfusion of the slices with l-cysteine (Cys), substrate of cystathionine ß-synthase (CBS, H(2)S synthase), could increase frequency of rhythmic respiratory discharge of the hypoglossal rootlets and prevent respiratory suppression induced by hypoxia, whereas perfusion with hydroxylamine (NH(2)OH, inhibitor of CBS) could postpone recovery of respiration from hypoxic inhibition. NH(2)OH also significantly enhanced hypoxia-induced increase in malondialdehyde (MDA) content of the slices. The hypoxia-induced up-regulation of c-fos mRNA could be markedly antagonized by S-adenosyl-l-methionine (SAM, activator of CBS), but greatly increased by NH(2)OH. Neither NH(2)OH, Cys nor SAM had any effect on expression of bcl-2 mRNA in hypoxic medullary slices. These results indicate that endogenously generated H(2)S was involved in protection of the medullary respiratory centers against hypoxic injury partly via antioxidation and down-regulation of c-fos.


Assuntos
Antioxidantes/fisiologia , Regulação para Baixo , Sulfeto de Hidrogênio/metabolismo , Hipóxia/metabolismo , Bulbo/metabolismo , Proteínas Proto-Oncogênicas c-fos/antagonistas & inibidores , RNA Mensageiro/antagonistas & inibidores , Insuficiência Respiratória/prevenção & controle , Animais , Animais Recém-Nascidos , Regulação para Baixo/genética , Feminino , Sulfeto de Hidrogênio/farmacologia , Hipóxia/genética , Hipóxia/prevenção & controle , Masculino , Bulbo/fisiologia , Substâncias Protetoras/metabolismo , Substâncias Protetoras/farmacologia , Proteínas Proto-Oncogênicas c-fos/biossíntese , Proteínas Proto-Oncogênicas c-fos/metabolismo , RNA Mensageiro/biossíntese , Ratos , Ratos Sprague-Dawley , Centro Respiratório/metabolismo , Insuficiência Respiratória/genética , Insuficiência Respiratória/metabolismo
18.
Respir Physiol Neurobiol ; 171(3): 181-6, 2010 May 31.
Artigo em Inglês | MEDLINE | ID: mdl-20406698

RESUMO

Hydrogen sulfide (H(2)S) has been shown to play a protective role in injury of cells induced by hypoxia. Little is known however about its effect on medullary hypoxia-induced rhythmic respiratory suppression. In the present study, a decrease in frequency of rhythmic discharge of hypoglossal rootlets was observed in medullary slices of neonatal rats perfused with 95% N(2)-5% CO(2) to produce hypoxia. Perfusion with NaHS (H(2)S donor) prevented the inhibitory effect of hypoxia on the burst activity of the rootlets, whereas such action of NaHS was suppressed by pretreatment with glibenclamide, a blocker of K(ATP) channels. In addition, the increase in malondialdehyde content and the up-regulation of c-fos mRNA expression of the slices induced by hypoxia was significantly reduced by NaHS. These results indicate that exogenous H(2)S may protect the medullary respiratory center against hypoxic injury via activation of K(ATP) channels, reduction of lipid peroxidation and down-regulation of c-fos.


Assuntos
Antioxidantes/farmacologia , Sulfeto de Hidrogênio/farmacologia , Hipóxia/prevenção & controle , Bulbo/efeitos dos fármacos , Respiração/efeitos dos fármacos , Animais , Animais Recém-Nascidos , Eletrofisiologia , Expressão Gênica/efeitos dos fármacos , Genes fos/efeitos dos fármacos , Hipóxia/fisiopatologia , Peroxidação de Lipídeos/efeitos dos fármacos , Bulbo/metabolismo , Bulbo/fisiopatologia , Técnicas de Cultura de Órgãos , Canais de Potássio/efeitos dos fármacos , Canais de Potássio/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/biossíntese , Proteínas Proto-Oncogênicas c-bcl-2/efeitos dos fármacos , Ratos , Reação em Cadeia da Polimerase Via Transcriptase Reversa
19.
Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 18(2): 296-9, 2010 Apr.
Artigo em Zh | MEDLINE | ID: mdl-20416155

RESUMO

This study was aimed to investigate the inhibitory effect of flavonoids of puerarin (PR) in different concentrations on proliferation of 4 kinds of acute myeloid leukemia (AML) cell lines (Kasumi-1, HL-60, NB4 and U937), and to explore its possible mechanism. The MTT method was used to detected the inhibitory effect of PR on proliferation of AML cell lines. The flow cytometry was adopted to determine the change of cell cycle in vitro. The results showed that a certain concentration of PR could inhibit the proliferation of these 4 cell lines effectively in time-and dose-dependent manners, and the intensity of inhibition on 4 kinds of AML cell lines was from high to low as follows: NB4>Kasumi-1>U937>HL-60. Meanwhile, PR could also change cycle process, cell proportion in G1/G0 phase decreased, cells in S phase increased and Sub-diploid peak also appeared. It is concluded that PR can selectively inhibit the proliferation of 4 AML cell lines and block cell cycle process, especially for NB4 cells.


Assuntos
Ciclo Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Isoflavonas/farmacologia , Leucemia Mieloide Aguda , Apoptose/efeitos dos fármacos , Linhagem Celular Tumoral , Células HL-60 , Humanos , Leucemia Mieloide Aguda/classificação , Leucemia Mieloide Aguda/patologia , Células U937
20.
Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 18(2): 326-9, 2010 Apr.
Artigo em Zh | MEDLINE | ID: mdl-20416161

RESUMO

This study was aimed to investigate the effects of flavonoids of puerarin (PR) on apoptosis of acute promyelocytic leukemia (APL) cell line NB4 cells and its mechanism. The NB4 were treated with PR in vitro, the MTT assay was used to detect the inhibitory effect of PR on cell proliferation. The apoptosis of NB4 cells were detected by flow cytometry labelled with Annexin V/PI. The expressions of pml/rar alpha, bcl-2 and survivin were detected by real time reverse transcription-polymerase chain reaction (real time RT-PCR), the expressions of JNK, p38 MAPK, FasL, caspase 3, caspase 8 were detected by Western blot. The results showed that with the increasing of PR concentrations, the apoptosis rates of NB4 cells were gradually elevated. Simultaneously, the mRNA expression of pml/rar alpha, bcl-2 and survivin decreased, while the protein expression of JNK, FasL, caspase 3 and caspase 8 increased, which presented the positive correlation to PR concentrations. When PR combined with arsenic trioxide (ATO), the expression levels of above mentioned mRNA and protein decreased or increased more significantly. It is concluded that PR can effectively induce the apoptosis of NB4 cells. PR combined with ATO displays synergistic effect. It may be triggered by the activation of JNK signal pathway.


Assuntos
Apoptose/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Isoflavonas/farmacologia , Leucemia Promielocítica Aguda/patologia , Proteínas Reguladoras de Apoptose/metabolismo , Linhagem Celular Tumoral , Humanos , Proteínas Quinases JNK Ativadas por Mitógeno/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA